Filing Flows › Jaguar Health (JAGX) › License revenue
Jaguar Health (JAGX) License revenue by quarter
Jaguar Health's License revenue was $43K in Q2 2026 (second quarter 2026), -100% from Q1 2026. Over the last 6 quarters it ranged from $42K (Q3 2025) to $19.0M (Q1 2026).
| Quarter | License revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $43K | -100% | 0% |
| Q1 2026 | $19.0M | 432× | 442× |
| Q4 2025 | $44K | +5% | — |
| Q3 2025 | $42K | -2% | — |
| Q2 2025 | $43K | 0% | — |
| Q1 2025 | $43K | — | — |
Q2 2026 at a glance
Jaguar Health, Q2 2026: revenue $1.2M (-59% year over year), operating margin -620.2%, net loss $12.8M, operating cash flow −$5.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Jaguar Health's License revenue?
Jaguar Health's License revenue was $43K in Q2 2026 (second quarter 2026), -100% from Q1 2026.
How has Jaguar Health's License revenue changed?
Over the last 6 quarters it ranged from $42K (Q3 2025) to $19.0M (Q1 2026).